SEI Investments’s Cumberland Pharmaceuticals CPIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-1,040
Closed -$2K 2459
2019
Q1
$2K Sell
1,040
-533
-34% -$3.09K ﹤0.01% 2855
2018
Q4
$4K Buy
1,573
+573
+57% +$3.43K ﹤0.01% 2596
2018
Q3
$1K Sell
1,000
-2,808
-74% -$16.5K ﹤0.01% 2493
2018
Q2
$23K Buy
3,808
+492
+15% +$3.08K ﹤0.01% 2748
2018
Q1
$22K Buy
3,316
+749
+29% +$5.16K ﹤0.01% 2619
2017
Q4
$19K Buy
2,567
+210
+9% +$1.54K ﹤0.01% 2613
2017
Q3
$17K Buy
2,357
+1,171
+99% +$8.1K ﹤0.01% 2536
2017
Q2
$8K Buy
1,186
+603
+103% +$3.98K ﹤0.01% 2629
2017
Q1
$4K Buy
583
+84
+17% +$509 ﹤0.01% 2609
2016
Q4
$3K Buy
499
+175
+54% +$913 ﹤0.01% 2658
2016
Q3
$2K Buy
324
+70
+28% +$329 ﹤0.01% 2640
2016
Q2
$1K Hold
254
﹤0.01% 2534
2016
Q1
$1K Buy
254
+129
+103% +$615 ﹤0.01% 2423
2015
Q4
$1K Sell
125
-120
-49% -$684 ﹤0.01% 2425
2015
Q3
$1K Buy
245
+12
+5% +$75 ﹤0.01% 2406
2015
Q2
$2K Buy
233
+2
+0.9% +$14 ﹤0.01% 2091
2015
Q1
$0 Buy
231
+40
+21% +$250 ﹤0.01% 2261
2014
Q4
$0 Buy
+191
New +$980 ﹤0.01% 2212

Other funds holding CPIX

SEI Investments's CPIX Position: Q2 2019 in Review

SEI Investments sold out of Cumberland Pharmaceuticals (CPIX) in Q2 2019, closing a stake of 1,040 shares — an estimated $2K sold.

SEI Investments first reported a position in CPIX in Q4 2014 and held it in 18 quarters. The position peaked at $23K in Q2 2018. 24 funds tracked by Wall St. Rank hold CPIX as of Q2 2019.

  • SEI Investments reported no remaining Cumberland Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • SEI Investments sold 1,040 Cumberland Pharmaceuticals shares in Q2 2019, an estimated $2K.
  • SEI Investments first reported a position in Cumberland Pharmaceuticals in Q4 2014 and held it in 18 quarters.
  • SEI Investments's Cumberland Pharmaceuticals position peaked at $23K in Q2 2018.
  • 24 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q2 2019.

Based on SEI Investments's 13F filing for Q2 2019, filed 14 Aug 2019.